Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
NCT04381897Phase 2Not yet recruiting
- Sponsor
- Johns Hopkins University
- Start
- Nov 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in Cornelia de Lange syndrome (CdLS), sponsored by Johns Hopkins University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
Cornelia de Lange syndrome (CdLS)
Beyond the preview
Go deeper on NCT04381897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04381897.